PapersPMID:31470778
The Effects of L-Carnitine Supplementation on Serum Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- findings
- 4
- compound
- 1
- endpoints
- 4
(R)-carnitine- Study, every finding
- meta-analysis
- Population, every finding
- Patients and healthy individuals in 67 randomized controlled trials
What moved
How to read these marks →“The pooled results indicated that L-carnitine administration led to a significant decrease in triglycerides (WMD: -10.35; 95% CI: -16.43, -4.27), total cholesterol (WMD: -9.47; 95% CI: - 13.23, -5.70) and LDL-cholesterol (LDL-C) concentrations (WMD: -6.25; 95% CI: -9.30, -3.21), and a significant increase in HDL-cholesterol (HDL-C) levels (WMD: 1.39; 95% CI: 0.21, 2.57).”
- Decreases total cholesterol (TC)
very limited
- Effect
- −9.47 mean difference, 95% CI −13.23 to −5.7
- Increases HDL cholesterol
very limited
- Effect
- 1.39 mean difference, 95% CI 0.21 to 2.57
- Decreases LDL cholesterol
very limited
- Effect
- −6.25 mean difference, 95% CI −9.3 to −3.21
- Decreases triglycerides
very limited
- Effect
- −10.35 mean difference, 95% CI −16.43 to −4.27
Study record
- Design
- meta-analysis
- Species
- human
- Population
- patients and healthy individuals in randomized controlled trials of L-carnitine
- Participants
- not reported
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 5